Log in
Login
Password
Remember
Lost password
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Shares  >  Nasdaq  >  Albany Molecular Research, Inc.    AMRI

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Upcoming events on ALBANY MOLECULAR RESEARCH,
08/04/15 Interim 2015 Earnings Release
08/04/15 | 08:30am Interim 2015 Earnings Call
11/10/15 Q3 2015 Earnings Release (Projected)
02/08/16 FY 2015 Earnings Release (Projected)
Past events on ALBANY MOLECULAR RESEARCH,
07/16/15 | 08:30am Acquisition of Gadea Pharmaceutical Group by Albany Molecular Research, Inc.Call
06/03/15 | 10:00am Annual General Meeting
06/01/15 | 03:30pm Jefferies Global Healthcare Conference
05/13/15 | 07:20pm Bank of America Merrill Lynch Health Care Conference
Upcoming sector events for ALBANY MOLECULAR RESEARCH,
08/04/15 ISIS PHARMACEUTICALS, INC. : Interim 2015 Earnings Release
08/04/15 | 07:00am INCYTE CORPORATION : Interim 2015 Earnings Release
08/04/15 | 10:00am INCYTE CORPORATION : Interim 2015 Earnings Call
08/04/15 | 11:30am ISIS PHARMACEUTICALS, INC. : Interim 2015 Earnings Call
Annual publications
Previous yearNext Year
Annual results2012201320142015 (e)2016 (e)
Sales
Million $
Released
Forecast
Spread
227
216
5,0%
247
248
-0,39%
277
280
-1,3%

378

443
Operating income (EBITDA)
Million $
Released
Forecast
Spread
32,4
29,1
11%
48,7
46,5
4,6%
46,0
50,7
-9,3%

66,9

84,2
Operating profit (EBIT)
Million $
Released
Forecast
Spread
15,0
11,6
29%
32,8
30,8
6,5%
27,1
33,8
-20%

43,3

56,0
Pre-Tax Profit (EBT)
 
Released
Forecast
Spread










Net income
Million $
Released
Forecast
Spread




-3,28
23,3
-114%

23,5

29,1
EPS
 $
Released
Forecast
Spread







0,85

0,99
Announcement Date02/12/201302/12/201402/12/2015

Quarterly / Semiannualy publications
Previous yearPrevious periodNext periodNext Year
Quarterly resultsQ3
2014
Q4
2014
Q1
2015
Q2
2015 (e)
Q3
2015 (e)
Sales
Million $
Released
Forecast
Spread
62,5
71,0
-12%
86,6
91,9
-5,8%
81,8
81,5
0,39%

85,0

93,9
Operating income (EBITDA)
Million $
Released
Forecast
Spread
3,02
13,0
-77%
16,6
22,8
-27%
14,5
15,0
-3,2%

15,3

16,4
Operating profit (EBIT)
Million $
Released
Forecast
Spread
-1,50
8,00
-119%
10,8
18,5
-41%
9,57
9,00
6,3%

9,55

10,7
Pre-Tax Profit (EBT)
 
Released
Forecast
Spread










Net income
Million $
Released
Forecast
Spread
-8,64
5,00
-273%
-1,86
12,2
-115%
-2,22
5,05
-144%

5,35

6,30
EPS
 $
Released
Forecast
Spread
-0,27
0,14
-293%
-0,06
0,37
-116%
-0,07
0,16
-145%

0,18

0,21
Announcement Date11/05/201402/12/201505/05/2015

© 2015 Thomson Reuters
© 2015 Factset
Advertisement
Net sales - Rate of surprise
Operating profit - Rate of surprise
EPS - Rate of surprise